Compare · head to head
Dong-A Socio vs Kaken Pharmaceutical
Dong-A Socio ranks higher overall — 360 rank 85 vs 27.
Dong-A Socio leads on Value (65 vs 51), Quality (74 vs 34), Growth (56 vs 37) and Sentiment (60 vs 38). Kaken Pharmaceutical leads on Safety (64 vs 33).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | Japan |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Medium |
| ISIN | KR7000640003 | JP3207000005 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 85 | 27 |
| Value | 65 | 51 |
| Quality | 74 | 34 |
| Growth | 56 | 37 |
| Safety | 33 | 64 |
| Sentiment | 60 | 38 |
| Quality details | ||
| Profitability | 69 | 44 |
| Cash Truth | 80 | 25 |
Dong-A Socio vs Kwangdong PharmaceuticalDong-A Socio vs Hanmi PharmaceuticalDong-A Socio vs JW PharmaceuticalDong-A Socio vs Aprogen BiologicsAdd a third stock →
Full analyses: Dong-A Socio · Kaken Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100